Startups

Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).

Summary

Seedtable Score
  • 17
Locations
Company Size
  • 11 to 50 employees
Last Stage Round
  • Series B
Industry

Total funding Amount

$61M

Fundraising History

  • Apr 03 '24 Series B
    $24M
  • Jan 01 '22 Series A
    $23M
  • Aug 01 '20 Series A
    $12M
  • Jun 01 '19 Seed
    $940K

Investors

  • Octopus Ventures
    Series A
  • Longwall Venture
    Series B
  • BlueYard Capital
    Series A
  • Agilent Technologies
    Series B